Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 GeneticVariation phenotype BEFREE The present study revealed that a heterozygous c.3508G>A mutation in the COL2A1 gene was involved in ANFH development in one Chinese family. 29750297 2018
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 GeneticVariation phenotype BEFREE We conclude that a mutation in the COL2A1 gene is the causative agent of ONFH in this family. 25050885 2014
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 GeneticVariation phenotype BEFREE In our research, we identify a heterozygous mutation (c.1888 G>A, p. Gly630Ser) in exon 29 of COL2A1 in the Gly-X-Y domain, in a Chinese family affected by LCPD and ANFH. 24949742 2014
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 GeneticVariation phenotype BEFREE A new type II collagenopathy, caused by the p.Gly1170Ser mutation of COL2A1, which presents as premature hip osteoarthritis (OA), avascular necrosis of the femoral head (ANFH) or Legg-Calvé-Perthes (LCP) disease, was recently found in several families with an inherited disease of the hip joint. 20204389 2010
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 GermlineCausalMutation phenotype ORPHANET All the patients with familial ANFH whom we studied carried COL2A1 mutations. 15930420 2005
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 GeneticVariation phenotype BEFREE No mutation was found in the COL2A1 coding region in sporadic cases of ANFH. 15930420 2005
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 Biomarker phenotype CTD_human
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.650 Biomarker phenotype GENOMICS_ENGLAND
Entrez Id: 59341
Gene Symbol: TRPV4
TRPV4
0.500 GermlineCausalMutation phenotype ORPHANET Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head. 27330106 2016
Entrez Id: 59341
Gene Symbol: TRPV4
TRPV4
0.500 Biomarker phenotype CTD_human
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.300 Biomarker phenotype CTD_human Corticosteroid-induced avascular necrosis. A clinical study of seventy-seven patients. 4326745 1971
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 Biomarker phenotype BEFREE The predicted target genes of the indicated miRNAs quantified by qRT-PCR, including IGF2, PDGFA, RUNX2, PTEN, and VEGF, were presumed to be altered in necrotic bone tissue of AIONFH patients. 31831773 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 Biomarker phenotype BEFREE Ginsenoside Rb1 prevents steroid‑induced avascular necrosis of the femoral head through the bone morphogenetic protein‑2 and vascular endothelial growth factor pathway. 31432121 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 AlteredExpression phenotype BEFREE ANFH treated with danshen combined with MSCs may promote revascularization by increasing the expression of VEGF and BMP-2 in the femoral head, promoting re-ossification and revascularization. 31258650 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 Biomarker phenotype BEFREE Bone mesenchymal stem cells co-expressing VEGF and BMP-6 genes to combat avascular necrosis of the femoral head. 29399103 2018
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 AlteredExpression phenotype BEFREE To investigate the role of miR-145 silencing in the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), B-cell lymphoma-2 (Bcl-2), BCL2-Associated X(bax) and caspase-3 in avascular necrosis of femoral head (ANFH). 28975994 2017
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 Biomarker phenotype BEFREE Our study proved that VEGF-loaded nanographene coated screws were effective in the treatment of femoral neck fracture and prevention of avascular necrosis of femoral head. 29117211 2017
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.070 Biomarker phenotype BEFREE AAV-mediated VEGF and BMP gene transfer stimulates angiogenesis and bone regeneration and may be a new therapeutic technique for the treatment of avascular necrosis of the femoral head (ANFH). 20581855 2010
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.040 AlteredExpression phenotype BEFREE We observed that MSCs from the steroid-associated ONFH group showed reduced proliferation ability, elevated ROS level, depressed MMP, weakened osteogenesis, and enhanced adipogenesis while low P-gp activity, transcription level of ABCB1, and oxidative stress-related genes as well as aberrant CpG islands hypermethylation of ABCB1 were also noted in steroid-associated ONFH group. 25112719 2015
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.040 GeneticVariation phenotype BEFREE MDR1 gene polymorphisms are associated with glucocorticoid-induced avascular necrosis of the femoral head in a Chinese population. 24387690 2014
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.040 GeneticVariation phenotype BEFREE ABCB1 gene polymorphisms and glucocorticoid-induced avascular necrosis of the femoral head susceptibility: a meta-analysis. 25544111 2014
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.040 Biomarker phenotype BEFREE The MDR1 2677 TT was also lower in the incidence of ONF (adjusted odds ratio = 0.21, 95% CI 0.018-1.301, p = 0.05). 18214345 2007
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.030 AlteredExpression phenotype BEFREE Effects of transplantation of FGF-2-transfected MSCs and XACB on TNF-α expression with avascular necrosis of the femoral head in rabbits. 30377228 2019
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.030 AlteredExpression phenotype BEFREE Effect of psoralen on the expression of PPARγ, osteocalcin, and trabecular bone area in rabbits with steroid-induced avascular necrosis of the femoral head. 30621711 2019
Entrez Id: 650
Gene Symbol: BMP2
BMP2
0.030 Biomarker phenotype BEFREE Inhibition and disruption of BMP-2 dimerization have been recognized as an attractive therapeutic strategy against ONFH. 30604108 2019